Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Eikelenboom

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis International|November 19, 2011
Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data InterpretationM J Eikelenboom, B M J Uitdehaag, A Petzold
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Opticospinal multiple sclerosis: a pathogenetically distinct form?M J Eikelenboom, J Killestein, B M Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
One year changes in disability in multiple sclerosis: neurological examination compared with patient self reportE L J Hoogervorst, M J Eikelenboom, B M J Uitdehaag, et al.
Journal of the Neurological Sciences|August 7, 2009
Gender differences in multiple sclerosis: cytokines and vitamin DM J Eikelenboom, J Killestein, J J Kragt, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 21, 2024
[Subarachnoid hemorrhage in a young girl]Roger Lodewijkx, Laura Draijer, Rosemarie de Ridder, et al.
Neurology|April 11, 2001
Comparisons of patient self-report, neurologic examination, and functional impairment in MSE L Hoogervorst, L M van Winsen, M J Eikelenboom, et al.
Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.
Journal of Neuroimmunology|November 26, 2002
Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosisM J Eikelenboom, J Killestein, T Izeboud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2005
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up studyA Petzold, M J Eikelenboom, G Keir, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis International|November 19, 2011
Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data InterpretationM J Eikelenboom, B M J Uitdehaag, A Petzold
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Opticospinal multiple sclerosis: a pathogenetically distinct form?M J Eikelenboom, J Killestein, B M Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
One year changes in disability in multiple sclerosis: neurological examination compared with patient self reportE L J Hoogervorst, M J Eikelenboom, B M J Uitdehaag, et al.
Journal of the Neurological Sciences|August 7, 2009
Gender differences in multiple sclerosis: cytokines and vitamin DM J Eikelenboom, J Killestein, J J Kragt, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 21, 2024
[Subarachnoid hemorrhage in a young girl]Roger Lodewijkx, Laura Draijer, Rosemarie de Ridder, et al.
Neurology|April 11, 2001
Comparisons of patient self-report, neurologic examination, and functional impairment in MSE L Hoogervorst, L M van Winsen, M J Eikelenboom, et al.
Neurology|October 1, 2010
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiencyV Worthington, J Killestein, M J Eikelenboom, et al.
Journal of Neuroimmunology|November 26, 2002
Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosisM J Eikelenboom, J Killestein, T Izeboud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 18, 2005
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up studyA Petzold, M J Eikelenboom, G Keir, et al.
Pageof 2